People · Operator
Named in public records as an officer, director or promoter · active 2011–2025 · Other, Healthtech, Other Technology, Mining & Resources
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Better Choice Co Inc. | — | Other | Series D+ | $280.1M | $119.1M | 2020 |
| Apache IS Holdings, LLC | — | Other | Series D+ | $165.0M | $2.8B | 2017 |
| Yooma Wellness Inc. | — | Healthtech | Series A | $17.7M | $19.2M | 2021 |
| Connectpay, Llc | — | Other Technology | Series A | $14.4M | $148.1M | 2019 |
| TX Terrace Hill Apts, LLC | — | Other | Series A | $11.5M | $117.0M | 2021 |
| Fairmount IV Portfolio, LLC | — | Other | Series A | $5.4M | $57.1M | 2021 |
| Fairmount V Portfolio, LLC | — | Other | Seed | $3.7M | $31.5M | 2022 |
| Hydros Bottle LLC | — | Other | Pre-Seed | $550K | $12.7M | 2011 |
| Hiro, Inc. | — | Other Technology | Pre-Seed | $525K | $22.2M | 2019 |
| Standard Uranium Ltd. | — | Mining & Resources | Pre-Seed | $506K | $448K | 2023 |
Michael Young at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Michael Young on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Lyndon Hansen | 3 | 7 |
| Tien Truong | 3 | 4 |
| Jason Pero | 2 | 6 |
| Jens Nielsen | 2 | 5 |
| Sam Newell | 2 | 3 |
| Sean McGrath | 1 | 11 |
| Jeff Davis | 1 | 7 |
| MARTIN BAJIC | 1 | 5 |
| Neil McCallum | 1 | 4 |
| Anthony Lacavera | 1 | 3 |
| Blair Jordan | 1 | 3 |
| Michael D. Young | 1 | 3 |
| Joshua Lebovic | 1 | 3 |
| Nadia Shabanza-Pero | 1 | 3 |
| William Meris | 1 | 3 |
| DONALD YOUNG | 1 | 3 |
| Jordan Greenberg | 1 | 3 |
| Lorne Abony | 1 | 3 |
| Garrett Ainsworth | 1 | 3 |
| Sammy Dorf | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.